A novel MAPT mutation associated with the clinical phenotype of progressive nonfluent aphasia

Chiara Villa, Laura Ghezzi, Anna M. Pietroboni, Chiara Fenoglio, Francesca Cortini, Maria Serpente, Claudia Cantoni, Elisa Ridolfi, Alessandra Marcone, Luisa Benussi, Roberta Ghidoni, Francesca Jacini, Andrea Arighi, Giorgio G. Fumagalli, Alessandra Mandelli, Giuliano Binetti, Stefano Cappa, Nereo Bresolin, Elio Scarpini, Daniela Galimberti

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

A number of mutations in microtubule associated protein tau gene (MAPT), causing frontotemporal lobar degeneration (FTLD) with tau pathology, are located in the four-repeated microtubule (MT) binding domains and affect the ability of tau to bind MTs. Here, we describe a novel variant lying in the second MT domain, found in a female patient diagnosed clinically with progressive nonfluent aphasia (PNFA), with a positive family history for dementia. At 65 years, she started developing progressive language deficits, characterized by expression difficulties and word coordination impairment. She came to our attention at 67 years. Her MMSE score was 22/30. A Brain CT scan showed mild diffuse cortical atrophy, ventricles' asymmetry (left > right), and very mild signs of chronic vasculopathy. Cerebrospinal fluid analysis showed normal amyloid-β 42, tau, and P-tau levels. She was diagnosed with PNFA according to current diagnostic criteria. A novel exon 10 MAPT variant was identified (g.123798G > A), which leads to an amino acidic change (p.Gly304Ser) in the second MT microtubule binding domain. In silico analysis predicted that this variant is damaging on protein structure and function. Additional 168 FTLD patients and 503 controls screened (1342 chromosomes) did not carry the variant, suggesting that it is a mutation rather than a polymorphism. The amino acid change likely compromises the ability of tau to properly regulate the dynamic behavior of microtubules.

Original languageEnglish
Pages (from-to)19-26
Number of pages8
JournalJournal of Alzheimer's Disease
Volume26
Issue number1
DOIs
Publication statusPublished - 2011

Fingerprint

Primary Progressive Nonfluent Aphasia
Microtubule-Associated Proteins
Microtubules
Phenotype
Mutation
Frontotemporal Lobar Degeneration
Aptitude
Genes
Ataxia
Amyloid
Computer Simulation
Heart Ventricles
Atrophy
Cerebrospinal Fluid
Dementia
Exons
Language
Chromosomes
Pathology
Amino Acids

Keywords

  • frontotemporal lobar degeneration (FTLD)
  • MAPT
  • mutation
  • phenotype
  • progressive nonfluent aphasia (PNFA)

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Geriatrics and Gerontology
  • Clinical Psychology

Cite this

A novel MAPT mutation associated with the clinical phenotype of progressive nonfluent aphasia. / Villa, Chiara; Ghezzi, Laura; Pietroboni, Anna M.; Fenoglio, Chiara; Cortini, Francesca; Serpente, Maria; Cantoni, Claudia; Ridolfi, Elisa; Marcone, Alessandra; Benussi, Luisa; Ghidoni, Roberta; Jacini, Francesca; Arighi, Andrea; Fumagalli, Giorgio G.; Mandelli, Alessandra; Binetti, Giuliano; Cappa, Stefano; Bresolin, Nereo; Scarpini, Elio; Galimberti, Daniela.

In: Journal of Alzheimer's Disease, Vol. 26, No. 1, 2011, p. 19-26.

Research output: Contribution to journalArticle

Villa, Chiara ; Ghezzi, Laura ; Pietroboni, Anna M. ; Fenoglio, Chiara ; Cortini, Francesca ; Serpente, Maria ; Cantoni, Claudia ; Ridolfi, Elisa ; Marcone, Alessandra ; Benussi, Luisa ; Ghidoni, Roberta ; Jacini, Francesca ; Arighi, Andrea ; Fumagalli, Giorgio G. ; Mandelli, Alessandra ; Binetti, Giuliano ; Cappa, Stefano ; Bresolin, Nereo ; Scarpini, Elio ; Galimberti, Daniela. / A novel MAPT mutation associated with the clinical phenotype of progressive nonfluent aphasia. In: Journal of Alzheimer's Disease. 2011 ; Vol. 26, No. 1. pp. 19-26.
@article{af688fb7197d47b6a687d303f4fb604d,
title = "A novel MAPT mutation associated with the clinical phenotype of progressive nonfluent aphasia",
abstract = "A number of mutations in microtubule associated protein tau gene (MAPT), causing frontotemporal lobar degeneration (FTLD) with tau pathology, are located in the four-repeated microtubule (MT) binding domains and affect the ability of tau to bind MTs. Here, we describe a novel variant lying in the second MT domain, found in a female patient diagnosed clinically with progressive nonfluent aphasia (PNFA), with a positive family history for dementia. At 65 years, she started developing progressive language deficits, characterized by expression difficulties and word coordination impairment. She came to our attention at 67 years. Her MMSE score was 22/30. A Brain CT scan showed mild diffuse cortical atrophy, ventricles' asymmetry (left > right), and very mild signs of chronic vasculopathy. Cerebrospinal fluid analysis showed normal amyloid-β 42, tau, and P-tau levels. She was diagnosed with PNFA according to current diagnostic criteria. A novel exon 10 MAPT variant was identified (g.123798G > A), which leads to an amino acidic change (p.Gly304Ser) in the second MT microtubule binding domain. In silico analysis predicted that this variant is damaging on protein structure and function. Additional 168 FTLD patients and 503 controls screened (1342 chromosomes) did not carry the variant, suggesting that it is a mutation rather than a polymorphism. The amino acid change likely compromises the ability of tau to properly regulate the dynamic behavior of microtubules.",
keywords = "frontotemporal lobar degeneration (FTLD), MAPT, mutation, phenotype, progressive nonfluent aphasia (PNFA)",
author = "Chiara Villa and Laura Ghezzi and Pietroboni, {Anna M.} and Chiara Fenoglio and Francesca Cortini and Maria Serpente and Claudia Cantoni and Elisa Ridolfi and Alessandra Marcone and Luisa Benussi and Roberta Ghidoni and Francesca Jacini and Andrea Arighi and Fumagalli, {Giorgio G.} and Alessandra Mandelli and Giuliano Binetti and Stefano Cappa and Nereo Bresolin and Elio Scarpini and Daniela Galimberti",
year = "2011",
doi = "10.3233/JAD-2011-102124",
language = "English",
volume = "26",
pages = "19--26",
journal = "Journal of Alzheimer's Disease",
issn = "1387-2877",
publisher = "IOS Press",
number = "1",

}

TY - JOUR

T1 - A novel MAPT mutation associated with the clinical phenotype of progressive nonfluent aphasia

AU - Villa, Chiara

AU - Ghezzi, Laura

AU - Pietroboni, Anna M.

AU - Fenoglio, Chiara

AU - Cortini, Francesca

AU - Serpente, Maria

AU - Cantoni, Claudia

AU - Ridolfi, Elisa

AU - Marcone, Alessandra

AU - Benussi, Luisa

AU - Ghidoni, Roberta

AU - Jacini, Francesca

AU - Arighi, Andrea

AU - Fumagalli, Giorgio G.

AU - Mandelli, Alessandra

AU - Binetti, Giuliano

AU - Cappa, Stefano

AU - Bresolin, Nereo

AU - Scarpini, Elio

AU - Galimberti, Daniela

PY - 2011

Y1 - 2011

N2 - A number of mutations in microtubule associated protein tau gene (MAPT), causing frontotemporal lobar degeneration (FTLD) with tau pathology, are located in the four-repeated microtubule (MT) binding domains and affect the ability of tau to bind MTs. Here, we describe a novel variant lying in the second MT domain, found in a female patient diagnosed clinically with progressive nonfluent aphasia (PNFA), with a positive family history for dementia. At 65 years, she started developing progressive language deficits, characterized by expression difficulties and word coordination impairment. She came to our attention at 67 years. Her MMSE score was 22/30. A Brain CT scan showed mild diffuse cortical atrophy, ventricles' asymmetry (left > right), and very mild signs of chronic vasculopathy. Cerebrospinal fluid analysis showed normal amyloid-β 42, tau, and P-tau levels. She was diagnosed with PNFA according to current diagnostic criteria. A novel exon 10 MAPT variant was identified (g.123798G > A), which leads to an amino acidic change (p.Gly304Ser) in the second MT microtubule binding domain. In silico analysis predicted that this variant is damaging on protein structure and function. Additional 168 FTLD patients and 503 controls screened (1342 chromosomes) did not carry the variant, suggesting that it is a mutation rather than a polymorphism. The amino acid change likely compromises the ability of tau to properly regulate the dynamic behavior of microtubules.

AB - A number of mutations in microtubule associated protein tau gene (MAPT), causing frontotemporal lobar degeneration (FTLD) with tau pathology, are located in the four-repeated microtubule (MT) binding domains and affect the ability of tau to bind MTs. Here, we describe a novel variant lying in the second MT domain, found in a female patient diagnosed clinically with progressive nonfluent aphasia (PNFA), with a positive family history for dementia. At 65 years, she started developing progressive language deficits, characterized by expression difficulties and word coordination impairment. She came to our attention at 67 years. Her MMSE score was 22/30. A Brain CT scan showed mild diffuse cortical atrophy, ventricles' asymmetry (left > right), and very mild signs of chronic vasculopathy. Cerebrospinal fluid analysis showed normal amyloid-β 42, tau, and P-tau levels. She was diagnosed with PNFA according to current diagnostic criteria. A novel exon 10 MAPT variant was identified (g.123798G > A), which leads to an amino acidic change (p.Gly304Ser) in the second MT microtubule binding domain. In silico analysis predicted that this variant is damaging on protein structure and function. Additional 168 FTLD patients and 503 controls screened (1342 chromosomes) did not carry the variant, suggesting that it is a mutation rather than a polymorphism. The amino acid change likely compromises the ability of tau to properly regulate the dynamic behavior of microtubules.

KW - frontotemporal lobar degeneration (FTLD)

KW - MAPT

KW - mutation

KW - phenotype

KW - progressive nonfluent aphasia (PNFA)

UR - http://www.scopus.com/inward/record.url?scp=80052841914&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80052841914&partnerID=8YFLogxK

U2 - 10.3233/JAD-2011-102124

DO - 10.3233/JAD-2011-102124

M3 - Article

VL - 26

SP - 19

EP - 26

JO - Journal of Alzheimer's Disease

JF - Journal of Alzheimer's Disease

SN - 1387-2877

IS - 1

ER -